SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.86−0.17 (-2.12%)
Close on Nov 13, 2026Market cap $1.59BP/E –Yield –
SELLAS Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
SELLAS Life Sciences's enterprise value was $1.56B on Nov 11, 2026, against $158.31M a year earlier. Over the last 5 years it ranged from $12.29M to $2.57B, with a median of $60.82M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.56B | +265.6% |
| 2025 | Dec 31, 2025 | $427.23M | +832.3% |
| 2024 | Dec 31, 2024 | $45.83M | +76.1% |
| 2023 | Dec 29, 2023 | $26.03M | -4.1% |
| 2022 | Dec 30, 2022 | $27.14M | -55.8% |
| 2021 | Dec 31, 2021 | $61.40M | +31.6% |
| 2020 | Dec 31, 2020 | $46.67M | +351.9% |
| 2019 | Dec 31, 2019 | $10.33M | -32.1% |
| 2018 | Dec 31, 2018 | $15.21M | -95.5% |
| 2017 | Dec 29, 2017 | $338.51M | -45.7% |
| 2016 | Dec 30, 2016 | $623.47M | -91.3% |
| 2015 | Dec 31, 2015 | $7.14B | +30.1% |
| 2014 | Dec 31, 2014 | $5.49B | -64.8% |
| 2013 | Dec 31, 2013 | $15.57B | +410.2% |
| 2012 | Dec 31, 2012 | $3.05B | +416.9% |
| 2011 | Dec 30, 2011 | $590.40M | – |
See a number that looks wrong?